Use the information for the question(s) below. Big Cure and Little Cure are both pharmaceutical companies. Big Cure presently has a potential "blockbuster" drug before the Food and Drug Administration (FDA) waiting for approval. If approved, Big Cure's blockbuster drug will produce $1 billion in net income for Big Cure. Little Cure has 10 separate less important drugs before the FDA waiting for approval. If approved, each of Little Cure's drugs would produce $100 million in net income for Little Cure. The probability of the FDA approving a drug is 50%. The standard deviation of Little Cure's average net income for their ten new drugs is closest to:
$500 million
$25 million
$50 million
$16 million
It is given that each drug can generate $100 Million if it is approved by FDA.
Therefore, we need to first calculate expected net income or Expected Return
It is calculated using the following formula
Expected Return ( Based on future data ) = Return of all drug items x Probability
= ($100 Million x 10) x 0.50
= $500 Million
Standard Deviation can be calculated by using the following formula
= Under root of [Probability x (Given Return - Expected Return)^2]
= Under root of [0.50 x ( $1000 Million - $500 Million )^2]
= Under root of [0.50 x 250000]
= Under root of 125000
= $353.55 Million
Therefore, standard deviation of Little Cure's average net income is closest to $500 Million.
For any query or clarification, please leave a comment.
Use the information for the question(s) below. Big Cure and Little Cure are both pharmaceutical companies....
8. Big Cure and Little Cure are both pharmaceutical companies. Big Cure presently has a potential "blockbuster" drug before the Food and Drug Administration (FDA) waiting for approval. If approved, Big Cure's blockbuster drug will produce $1 billion in net income for Big Cure. Little Cure has ten separate, less important drugs before the FDA waiting for approval. If approved, each of Little Cure's drugs would produce $50 million in net income. The probability of the FDA approving a drug...
4. Suppose that a stock gave a realized return of 20% over a two-year time period and a 10% return over the third year. The geometric average annual return is ________. (2 points) A) 8.28% B) 12.43% C) 14.08% D) 16.57% 5. Bear Stearns' stock price closed at $98, $103, $58, $29, $4 over five successive weeks. The weekly standard deviation of the stock price calculated from this sample is ________. (2 points) A) $30.07 B) $49.40 C) $42.96 D)...
Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. The FDA wants to set up a hypothesis test to show that the new drug is...
Prezcott Pharma Developed in association with Dr. Cem Saydam, Belk College of Business, UNC Charlotte. Anyone who has suffered with an acute or chronic illness is probably very appreciative for whatever drugs are available to cure or manage the disease. In the United States the Food and Drug Administration (FDA) is the governmental agency that oversees the drug development, testing, and monitoring process see http://www.fda.gov /Drugs/). Developing new drugs that safely address particular medical issues without producing unpleasant or dangerous...
Approximately 14 million Americans are addicted to drugs and alcohol. The federal government estimates that these addicts cost the U.S. economy $300 billion in medical expenses and lost productivity. Despite the enormous potential market, many biotech companies have shied away from funding research and development (R&D) initiatives to find a cure for drug and alcohol addiction. Your firm – Drug Abuse Sciences (DAS) – is a notable exception. It has spent $245 million to date working on a cure, but...
Big Problems for Big Pharma - The United States is facing an opioid epidemic. In 2015 alone, 33,000 people within the United States died from an opioid related death. Opioids are narcotics that produce a morphine-like effect. They work by binding to opioid receptors within the body and reducing the body’s ability to send pain messages to the brain. Common opioids include hydrocodone, morphine, fentanyl, and oxycodone. Over half of the opioid-related deaths are linked to prescription opioid use, while...
Approximately 14 million Americans are addicted to drugs and alcohol. The federal government estimates that these addicts cost the U.S. economy $300 billion in medical expenses and lost productivity. Despite the enormous potential market, many biotech companies have shied away from funding research and development (R&D) initiatives to find a cure for drug and alcohol addiction. Your firm – Drug Abuse Sciences (DAS) – is a notable exception. It has spent $230 million to date working on a cure, but...
Approximately 14 million Americans are addicted to drugs and alcohol. The federal government estimates that these addicts cost the U.S. economy $300 billion in medical expenses and lost productivity. Despite the enormous potential market, many biotech companies have shied away from funding research and development (R&D) initiatives to find a cure for drug and alcohol addiction. Your firm – Drug Abuse Sciences (DAS) – is a notable exception. It has spent $230 million to date working on a cure, but...
Approximately 14 million Americans are addicted to drugs and alcohol. The federal government estimates that these addicts cost the U.S. economy $300 billion in medical expenses and lost productivity. Despite the enormous potential market, many biotech companies have shied away from funding research and development (R&D) initiatives to find a cure for drug and alcohol addiction. Your firm - Drug Abuse Sciences (DAS) - is a notable exception. It has spent $235 million to date working on a cure, but...
Approximately 14 million Americans are addicted to drugs and alcohol. The federal government estimates that these addicts cost the U.S. economy $300 billion in medical expenses and lost productivity. Despite the enormous potential market, many biotech companies have shied away from funding research and development (R&D) initiatives to find a cure for drug and alcohol addiction. Your firm – Drug Abuse Sciences (DAS) – is a notable exception. It has spent $240 million to date working on a cure, but...